Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ventavis in Postembolic Residual Pulmonary Hypertension
NCT02238535Phase 2Unknown
- Sponsor
- E. Meshalkin National Medical Research Centre
- Start
- Sep 2014
- Primary completion
- Mar 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of iloprost in pulmonary hypertension (PH), sponsored by E. Meshalkin National Medical Research Centre. Status: unknown.
02
Drugs
iloprost
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT02238535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02238535.